Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) insider upped their holding by 67% earlier this yr

Viewing insider transactions for Cyclerion Therapeutics, Inc.’s (NASDAQ:CYCN ) during the last yr, we see that insiders have been internet patrons. Which means that a bigger variety of shares have been bought by insiders in relation to shares bought.

Whereas insider transactions usually are not crucial factor on the subject of long-term investing, logic dictates it is best to pay some consideration as to if insiders are shopping for or promoting shares.

See our newest evaluation for Cyclerion Therapeutics

The Final 12 Months Of Insider Transactions At Cyclerion Therapeutics

The CEO, Interim CFO Peter Hecht made the largest insider

Read More